Where the guidance comes from
The CDC’s injection safety pages are addressed mainly to healthcare providers, but the agency says understanding safe injection practices can protect anyone who receives an injection [1].
For an injection you give yourself, the closest equivalent is the Instructions for Use (IFU) that comes with your pen or vial. The labels expect training first: the Zepbound® label asks prescribers to train patients on the exact presentation they will use, and again if it changes [4]. MedlinePlus, the National Library of Medicine’s consumer site, adds plain-language steps for giving an injection under the skin [5].
One needle, one syringe, only one time
This is the CDC’s short rule. Once used, a needle and syringe both count as contaminated. Reusing them, or using them to enter a vial that someone else also draws from, can carry hepatitis B, hepatitis C, possibly HIV, and bacterial or fungal infections from one person to the next [1][2]. The CDC adds that changing only the needle does not make a used syringe safe for another person [2].
The pen instructions apply the same idea to a single user. The Ozempic® IFU asks for a new needle at every injection and gives the reasons: it lowers the chance of contamination and infection, and it avoids leaking medicine and blocked needles that can lead to a wrong dose. A bent or damaged needle is never used [3]. The Zepbound® label asks vial users for a new syringe and needle each time [4]. MedlinePlus says the same for any syringe, and to throw away one whose wrapping or cap is broken or missing [5]. Sharing has its own warning on every pen label and its own article.
Check the medicine before every dose
- Name and label: the Ozempic® IFU asks you to confirm the name and the coloured label on the pen, which matters most when you keep more than one medicine at home [3].
- Appearance: Ozempic® should look clear and colourless through the pen window, and the IFU says not to use it if it is cloudy or has particles. The Zepbound® label describes its solution as clear and colourless to slightly yellow and says not to use it if you see particles or discolouration [3][4].
- Dates: the expiry date is on the label, and MedlinePlus says not to use medicine that is out of date [6]. In-use limits after opening differ by product and are covered in the multi-dose vial and storage articles.
- Presentation: the Ozempic® label now lists single-dose prefilled syringes alongside the multi-dose pens; a single-dose syringe is thrown away after use [3].
- Condition: the Ozempic® IFU says that if a pen is dropped or you suspect a problem, you attach a new needle and check the flow before injecting. It also says never to use a syringe to draw medicine out of the pen [3].
Clean hands and clean skin
The Ozempic® IFU starts with washing your hands with soap and water. Just before the injection, it asks you to wipe the chosen spot with an alcohol swab and let the skin dry before inserting the needle [3]. MedlinePlus describes the same steps in more detail: wash thoroughly, including between the fingers, dry with a clean paper towel, wipe the site in a circle moving outward from where the needle will go, and let it dry [5].
MedlinePlus also says the skin you inject into should be healthy, without redness, swelling, scarring or bruising, and that the site should change from one injection to the next [5]. The CDC’s guidance for clinics calls the whole approach aseptic technique and stresses a clean preparation area away from sinks and other water sources, with sealed needles and syringes and alcohol wipes ready [2]. The idea carries over to a kitchen table: a clean, dry surface, supplies left in their packaging until needed, and no rushing.
Vials: single-dose and multi-dose
The CDC explains the difference. A single-dose vial is meant for one injection; it usually has no preservative, so leftover liquid is not saved for later or combined with other vials. A multi-dose vial is approved for repeated use and usually contains a preservative, but the CDC notes that the preservative has no effect on viruses and does not fully protect against bacteria [2]. A new needle and syringe are always used to draw from it [2][4].
Its clinic guidance adds three habits: no needle left in the rubber stopper between uses, injections prepared close to the time they are given, and any vial of doubtful sterility thrown away [2]. MedlinePlus adds wiping the rubber top with an alcohol pad and writing the opening date on a vial you will use more than once [6]. How long an opened vial may be used is explained in the article on multi-dose vials and the 28-day rule.
What studies say about reusing a needle
The evidence on needle reuse comes almost entirely from people who inject insulin, not from GLP-1 or other peptide users. A 2016 systematic review and meta-analysis found 25 studies, all at high risk of bias. Pooled data showed no clear link between reuse and infection at the injection site, but cross-sectional studies linked reuse with lipohypertrophy and two studies with more pain; the authors concluded there was no clear evidence for or against the practice and called for better research [8].
A 2026 meta-analysis of 51 studies on risk factors for lipohypertrophy found that injecting without proper site rotation was the strongest factor, followed by needle reuse [9]. Several of its authors work for or advise a needle manufacturer, and the studies are observational, so the results show associations rather than proof of cause [9]. None of this changes the instruction in the labels themselves, which ask for a new needle every time [3][4].
After the injection
The Ozempic® label says to take the needle off and discard it safely after each injection, and to store the pen without a needle attached. Its IFU asks caregivers to take care with used needles and to keep pens and needles away from others, especially children [3]. The FDA’s first step for any used sharp is to put it straight into a sharps disposal container kept out of reach of children and pets; the sharps disposal article covers the rest [7].
When unsafe injections happen in clinics, the CDC’s answer is to tell the people affected and advise follow-up testing [2]. If a needle or syringe may have been used by someone else at home, raise it with your clinician promptly rather than waiting.
Ozempic® is a registered trademark of Novo Nordisk A/S. Zepbound® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| After a dose, a swollen face, lips, tongue or throat, difficulty breathing or swallowing, a racing heartbeat or feeling faint | Emergency care (911 or your local number) | Emergency | OZEMPIC® Medication Guide [3] |
| Redness, swelling, red streaks and fever around an injection site | Your healthcare provider | Today | MedlinePlus, subcutaneous injections [5] |
| A needle, syringe or pen may have been used by someone else before you | Your clinician, who can advise on testing | Today | CDC [1][2] |
| The medicine is cloudy, discoloured or has particles | Do not inject it; ask your pharmacist | Today | Ozempic® IFU; Zepbound® label 2.4 [3][4] |
| The usual site is red, swollen, scarred or bruised | Use another site and mention it at your next appointment | At your next appointment | MedlinePlus [5] |